MAIA Biotechnology to initiate digital asset treasury strategy

MAIA Biotechnology (MAIA) announced its launch of a new digital asset treasury strategy focused on top-tier cryptocurrency assets. MAIA’s Board of Directors has authorized holdings of up to 90% of the Company’s liquid assets in various cryptocurrencies. Corporate officers are authorized to purchase and sell Bitcoin, Ethereum, and USD Coin initially. Management will regularly consult with the Board on cryptocurrency transactions and holdings, cybersecurity procedures, accounting policies, risks, and material developments. MAIA also intends to have its Board approve the formation of a Digital Assets Advisory Board to support the execution of the digital asset treasury strategy.